Lionel D. Lewis, MD, MA, MB BCh, has been elected as a fellow of the British Pharmacological Society, a premier global society in the science of pharmacology.
Press Release
Dartmouth-led Research Featured in National Journal Focused on Health System Performance
New findings published by Dartmouth researchers and featured in a special issue of Health Services Research, are helping to generate new insights and knowledge about the prevalence, roles, and impact of integrated health systems.
Dartmouth Receives $2.4 Million to Aid Healthcare Providers’ COVID-19 Response
Researchers at Dartmouth’s Geisel School of Medicine have been awarded $2.4 million in federal funding to support ongoing studies aimed at enhancing American healthcare providers’ response to the COVID-19 pandemic.
International Study Shows that Active Surveillance Holds Promise as a Treatment Option for Low-Risk Thyroid Cancer
Results from a new study co-led by researchers at Dartmouth’s Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan, show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.
Dartmouth-Hitchcock and Geisel School of Medicine Name Steven L. Bernstein, MD, as Chief Research Officer and Associate Dean of Clinical Research
Steven L. Bernstein, MD, has been named as the inaugural Chief Research Officer for Dartmouth-Hitchcock (D-H), Associate Dean of Clinical Research at the Geisel School of Medicine at Dartmouth, and Director of the C. Everett Koop Institute at Geisel.
Researchers Find Source of Breast Tumor Heterogeneity and Pathway that Limits Emergence
A team of researchers led by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has identified mammary basal cells as a contributing source to the development of heterogeneous tumor cell subpopulations and found that activation of the PKA signaling pathway can curtail their emergence, providing opportunities for new therapeutic approaches to breast cancer.
Geisel Study Examines Well Water Testing Promotion in Pediatric Primary Care
Findings from a new study conducted by a team of researchers at Dartmouth’s Geisel School of Medicine and published in the journal Preventive Medicine Reports, show that involving pediatric practices in the promotion of private well water testing can influence parental compliance.
Avasthi Named President of International Science Board
Prachee Avasthi, PhD, an associate professor of biochemistry and cell biology at Dartmouth’s Geisel School of Medicine, has been named president of the ASAPbio (Accelerating Science and Publication in biology) organization—a scientist-driven nonprofit promoting transparency and innovation in life sciences communication.
Alumni Gifts Will Accelerate Innovations in Cancer Prevention and Treatment
Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer which will allow for innovations to the marketplace for the benefit of cancer patients, and provide Dartmouth students with learning opportunities in biomedical entrepreneurship.
Dartmouth TB Vaccine Moves Forward After Successful Phase 2 Trial
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine.
Upcoming Events
- Psychiatry Grand Rounds April 19, 2024
- M&I Thesis Defense - Jordan Fredriksen Isaacs April 19, 2024
- Neurology Grand Rounds April 19, 2024
- Henrique Borges da Silva seminar (Jordan's outside examiner) April 19, 2024
- Microbiology & Immunology Seminar Series - Rong Li, Ph.D. April 22, 2024
- Psychiatry Grand Rounds April 23, 2024
- DCC Grand Rounds with Audrey Calderwood, MD, MS April 23, 2024
- Implementation Science Fundamentals: Measuring Implementation Context, Process, & Outcomes April 23, 2024
- Pediatric Grand Rounds April 24, 2024
- Preventing Overdiagnosis Webinar: Why cancer is our most feared disease. April 25, 2024
- Discovery Science Seminar Series April 29, 2024
- Microbiology & Immunology Seminar Series - Akhenaton-Andrew Dhafir Jones III, Ph.D. April 29, 2024